248 related articles for article (PubMed ID: 12470069)
1. Hexadentate hydroxypyridonate iron chelators based on TREN-Me-3,2-HOPO: variation of cap size.
Xu J; O'Sullivan B; Raymond KN
Inorg Chem; 2002 Dec; 41(25):6731-42. PubMed ID: 12470069
[TBL] [Abstract][Full Text] [Related]
2. The effect of ligand scaffold size on the stability of tripodal hydroxypyridonate gadolinium complexes.
O'Sullivan B; Doble DM; Thompson MK; Siering C; Xu J; Botta M; Aime S; Raymond KN
Inorg Chem; 2003 Apr; 42(8):2577-83. PubMed ID: 12691564
[TBL] [Abstract][Full Text] [Related]
3. Mixed hydroxypyridinonate ligands as iron chelators.
Cohen SM; O'Sullivan B; Raymond KN
Inorg Chem; 2000 Sep; 39(19):4339-46. PubMed ID: 11196930
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of homochiral tris(2-alkyl-2-aminoethyl)amine derivatives from chiral alpha-amino aldehydes and their application in the synthesis of water soluble chelators.
Hajela SP; Johnson AR; Xu J; Sunderland CJ; Cohen SM; Caulder DL; Raymond KN
Inorg Chem; 2001 Jun; 40(13):3208-16. PubMed ID: 11399194
[TBL] [Abstract][Full Text] [Related]
5. Thorium(IV) complexes of bidentate hydroxypyridinonates.
Xu J; Whisenhunt DW; Veeck AC; Uhlir LC; Raymond KN
Inorg Chem; 2003 Apr; 42(8):2665-74. PubMed ID: 12691574
[TBL] [Abstract][Full Text] [Related]
6. Plutonium(IV) sequestration: structural and thermodynamic evaluation of the extraordinarily stable cerium(IV) hydroxypyridinonate complexes.
Xu J; Radkov E; Ziegler M; Raymond KN
Inorg Chem; 2000 Sep; 39(18):4156-64. PubMed ID: 11198875
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and thermodynamic evaluation of mixed hexadentate linear iron chelators containing hydroxypyridinone and terephthalamide units.
Abergel RJ; Raymond KN
Inorg Chem; 2006 May; 45(9):3622-31. PubMed ID: 16634594
[TBL] [Abstract][Full Text] [Related]
8. Terephthalamide-containing analogues of TREN-Me-3,2-HOPO.
Jurchen KM; Raymond KN
Inorg Chem; 2006 Feb; 45(3):1078-90. PubMed ID: 16441116
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.
Cohen SM; Xu J; Radkov E; Raymond KN; Botta M; Barge A; Aime S
Inorg Chem; 2000 Dec; 39(25):5747-56. PubMed ID: 11151375
[TBL] [Abstract][Full Text] [Related]
10. Copper(I) complexes, copper(I)/O(2) reactivity, and copper(II) complex adducts, with a series of tetradentate tripyridylalkylamine tripodal ligands.
Schatz M; Becker M; Thaler F; Hampel F; Schindler S; Jacobson RR; Tyeklár Z; Murthy NN; Ghosh P; Chen Q; Zubieta J; Karlin KD
Inorg Chem; 2001 May; 40(10):2312-22. PubMed ID: 11327908
[TBL] [Abstract][Full Text] [Related]
11. Fast biological iron chelators: kinetics of iron removal from human diferric transferrin by multidentate hydroxypyridonates.
Turcot I; Stintzi A; Xu J; Raymond KN
J Biol Inorg Chem; 2000 Oct; 5(5):634-41. PubMed ID: 11085654
[TBL] [Abstract][Full Text] [Related]
12. The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogue.
Yokel RA; Fredenburg AM; Durbin PW; Xu J; Rayens MK; Raymond KN
J Pharm Sci; 2000 Apr; 89(4):545-55. PubMed ID: 10737916
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a ligand based upon a new entry into the 3-hydroxy-N-alkyl-2(1H)-pyridinone ring system and thermodynamic evaluation of its gadolinium complex.
Johnson AR; O'Sullivan B; Raymond KN
Inorg Chem; 2000 Jun; 39(12):2652-60. PubMed ID: 11197022
[TBL] [Abstract][Full Text] [Related]
14. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands.
Pierre VC; Melchior M; Doble DM; Raymond KN
Inorg Chem; 2004 Dec; 43(26):8520-5. PubMed ID: 15606201
[TBL] [Abstract][Full Text] [Related]
15. Para-derivatized pybox ligands as sensitizers in highly luminescent Ln(III) complexes.
de Bettencourt-Dias A; Barber PS; Viswanathan S; de Lill DT; Rollett A; Ling G; Altun S
Inorg Chem; 2010 Oct; 49(19):8848-61. PubMed ID: 20809608
[TBL] [Abstract][Full Text] [Related]
16. 1,2-HOIQO--a highly versatile 1,2-HOPO analogue.
Seitz M; Pluth MD; Raymond KN
Inorg Chem; 2007 Jan; 46(2):351-3. PubMed ID: 17279805
[TBL] [Abstract][Full Text] [Related]
17. Copper(I)-dioxygen reactivity of [(L)Cu(I)](+) (L = tris(2-pyridylmethyl)amine): kinetic/thermodynamic and spectroscopic studies concerning the formation of Cu-O2 and Cu2-O2 adducts as a function of solvent medium and 4-pyridyl ligand substituent variations.
Zhang CX; Kaderli S; Costas M; Kim EI; Neuhold YM; Karlin KD; Zuberbühler AD
Inorg Chem; 2003 Mar; 42(6):1807-24. PubMed ID: 12639113
[TBL] [Abstract][Full Text] [Related]
18. 1,2-hydroxypyridonate/terephthalamide complexes of gadolinium(III): synthesis, stability, relaxivity, and water exchange properties.
Werner EJ; Kozhukh J; Botta M; Moore EG; Avedano S; Aime S; Raymond KN
Inorg Chem; 2009 Jan; 48(1):277-86. PubMed ID: 19032045
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and solid state structures of tris(pyrazolyl)methane complexes of sodium, potassium, calcium, and strontium: comparison of structures with analogous complexes of lead(II).
Reger DL; Little CA; Smith MD; Rheingold AL; Liable-Sands LM; Yap GP; Guzei IA
Inorg Chem; 2002 Jan; 41(1):19-27. PubMed ID: 11782139
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
